Annual report
7731.TEDINET S100ODD2
Period2021-04-01 → 2022-03-31
Filed2022-06-29
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 154
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥539.6bn | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥451.2bn | 2020-04-01 → 2021-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥591.0bn | 2019-04-01 → 2020-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥708.7bn | 2018-04-01 → 2019-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥717.1bn | 2017-04-01 → 2018-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥49.9bn | 2021-04-01 → 2022-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | −¥56.2bn | 2020-04-01 → 2021-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥57.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥45.3bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥42.7bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥34.5bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥7.7bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥66.5bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥34.8bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥42.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥57.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | −¥34.5bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss IFRS |
| Net income | −¥45.3bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥11.9bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥87.9bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥56.3bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Total assets | ¥1.04T | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥989.7bn | at 2021-03-31 | Cons. | Assets IFRS |
| Total assets | ¥1.01T | at 2020-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥1.13T | at 2019-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥1.10T | at 2018-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥439.6bn | at 2022-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥451.0bn | at 2021-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥600.0bn | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥538.7bn | at 2021-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥541.8bn | at 2020-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥597.7bn | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥537.6bn | at 2021-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥540.7bn | at 2020-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥615.9bn | at 2019-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥572.9bn | at 2018-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥370.3bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥351.8bn | at 2021-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥324.0bn | at 2020-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥411.1bn | at 2019-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥388.4bn | at 2018-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥31.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥5.0bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥16.4bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥68.9bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥125.1bn | 2017-04-01 → 2018-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥385m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥18.0bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥21.3bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥25.3bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥34.8bn | 2017-04-01 → 2018-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥26.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥5.0bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥72.7bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥21.6bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥20.0bn | 2017-04-01 → 2018-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥116.23 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-93.96 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥19.93 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥167.86 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥87.76 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥115.58 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-93.96 | 2020-04-01 → 2021-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥19.85 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥167.3 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥87.49 | 2017-04-01 → 2018-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥1,627.34 | at 2022-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,464.06 | at 2021-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,472.69 | at 2020-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,554.34 | at 2019-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,445.92 | at 2018-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 57.5% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 54.3% | at 2021-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 53.7% | at 2020-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 54.3% | at 2019-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 52.2% | at 2018-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 7.5% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -6.4% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 1.3% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 11.2% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 6.3% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 18,437 | at 2022-03-31 | Cons. | Number of employees |
| Revenue | ¥348.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥302.1bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥406.2bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥509.5bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥482.1bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥7.6bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | −¥41.6bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥21.0bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥14.5bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥27.3bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥46.3bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥44.6bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥36.6bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥31.4bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥29.3bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥60.8bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | −¥9.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥51.6bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥34.1bn | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥721.3bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥734.8bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥679.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥796.0bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥780.5bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥359.0bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥392.6bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥362.3bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥342.2bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥276.8bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥356.3bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥329.6bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥209.6bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥224.5bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥79.88 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥165.52 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-25.03 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥130.27 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥86 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥79.43 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥164.67 | 2020-04-01 → 2021-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥129.83 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥85.74 | 2017-04-01 → 2018-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥40 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥36 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥980.75 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥926.32 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥748.84 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥894.61 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥827.62 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 49.9% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.3% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.5% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.5% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.0% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.4% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.8% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -3.1% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.1% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.9% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 378,337,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 378,337,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 378,337,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 400,879,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 400,879,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 4,174 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 4,183 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 4,442 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 4,398 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 4,444 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 78
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥77.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥77.0bn |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥551.2bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥16.9bn |
| Components Businessreportable segment | employees | at 2022-03-31 | 654 pure |
| Components Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥50.7bn |
| Components Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥40.9bn |
| Components Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥9.8bn |
| Components Businessreportable segment | segment assets | at 2022-03-31 | ¥42.0bn |
| Components Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥12.7bn |
| Healthcare Businessreportable segment | employees | at 2022-03-31 | 1761 pure |
| Healthcare Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥73.4bn |
| Healthcare Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥73.2bn |
| Healthcare Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥189m |
| Healthcare Businessreportable segment | segment assets | at 2022-03-31 | ¥102.2bn |
| Healthcare Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥4.4bn |
| Imaging Products Businessreportable segment | employees | at 2022-03-31 | 7079 pure |
| Imaging Products Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥179.0bn |
| Imaging Products Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥178.2bn |
| Imaging Products Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥720m |
| Imaging Products Businessreportable segment | segment assets | at 2022-03-31 | ¥80.0bn |
| Imaging Products Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥19.1bn |
| Industrial Metrology And Othersreportable segment | employees | at 2022-03-31 | 5064 pure |
| Industrial Metrology And Othersreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥102.2bn |
| Industrial Metrology And Othersreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥36.0bn |
| Industrial Metrology And Othersreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥66.2bn |
| Industrial Metrology And Othersreportable segment | segment assets | at 2022-03-31 | ¥72.1bn |
| Industrial Metrology And Othersreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥3.0bn |
| Precision Equipment Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥211.4bn |
| Precision Equipment Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥211.2bn |
| Precision Equipment Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥157m |
| Precision Equipment Businessreportable segment | segment assets | at 2022-03-31 | ¥192.0bn |
| Precision Equipment Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥27.7bn |
| Precision Machineryreportable segment | employees | at 2022-03-31 | 3181 pure |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥616.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥539.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥77.0bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥488.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥66.9bn |
| Reconciling Itemsreconciling | revenue | 2020-04-01 → 2021-03-31 | −¥84.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2020-04-01 → 2021-03-31 | −¥84.4bn |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥531.3bn |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2021-03-31 | −¥15.1bn |
| Components Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥32.7bn |
| Components Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥25.8bn |
| Components Businessreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥6.9bn |
| Components Businessreportable segment | segment assets | at 2021-03-31 | ¥31.9bn |
| Components Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥187m |
| Healthcare Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥63.0bn |
| Healthcare Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥62.8bn |
| Healthcare Businessreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥162m |
| Healthcare Businessreportable segment | segment assets | at 2021-03-31 | ¥93.8bn |
| Healthcare Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | −¥3.1bn |
| Imaging Products Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥151.4bn |
| Imaging Products Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥150.2bn |
| Imaging Products Businessreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥1.2bn |
| Imaging Products Businessreportable segment | segment assets | at 2021-03-31 | ¥68.4bn |
| Imaging Products Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | −¥36.4bn |
| Industrial Metrology And Othersreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥103.3bn |
| Industrial Metrology And Othersreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥27.6bn |
| Industrial Metrology And Othersreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥75.7bn |
| Industrial Metrology And Othersreportable segment | segment assets | at 2021-03-31 | ¥73.2bn |
| Industrial Metrology And Othersreportable segment | segment profit | 2020-04-01 → 2021-03-31 | −¥1.2bn |
| Precision Equipment Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥185.2bn |
| Precision Equipment Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥184.8bn |
| Precision Equipment Businessreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥378m |
| Precision Equipment Businessreportable segment | segment assets | at 2021-03-31 | ¥191.2bn |
| Precision Equipment Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | −¥643m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥535.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥451.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥84.4bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥458.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | −¥41.1bn |
| Components Businessreportable segment | employees | at 2022-03-31 | 428 pure |
| Healthcare Businessreportable segment | employees | at 2022-03-31 | 282 pure |
| Imaging Products Businessreportable segment | employees | at 2022-03-31 | 606 pure |
| Industrial Metrology And Othersreportable segment | employees | at 2022-03-31 | 1075 pure |
| Precision Equipment Businessreportable segment | employees | at 2022-03-31 | 1225 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,173
| Item | Context | Value | Unit |
|---|---|---|---|
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 1.159 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 1.100 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 0.996 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.415 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.443 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E02271-000ImagingProductsBusinessReportableSegmentMember | 7079 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E02271-000PrecisionMachineryReportableSegmentsMember | 3181 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E02271-000HealthcareBusinessReportableSegmentMember | 1761 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E02271-000ComponentsBusinessReportableSegmentMember | 654 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E02271-000IndustrialMetrologyAndOthersReportableSegmentMember | 5064 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 698 | |
| Number of employees | CurrentYearInstant | 18437 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 4174 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 43.5 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 16.6 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 8118353 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02271-000ImagingProductsBusinessReportableSegmentMember | 606 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02271-000PrecisionEquipmentBusinessReportableSegmentMember | 1225 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02271-000HealthcareBusinessReportableSegmentMember | 282 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02271-000ComponentsBusinessReportableSegmentMember | 428 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02271-000IndustrialMetrologyAndOthersReportableSegmentMember | 1075 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 558 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 4174 | |
| Research and development expenses research and development activities | CurrentYearDuration | 61107000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02271-000ImagingProductsBusinessReportableSegmentMember | 15225000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02271-000PrecisionEquipmentBusinessReportableSegmentMember | 28609000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02271-000HealthcareBusinessReportableSegmentMember | 6091000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02271-000ComponentsBusinessReportableSegmentMember | 2887000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02271-000IndustrialMetrologyAndOthersReportableSegmentMember | 8509000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 42143000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02271-000ImagingProductsBusinessReportableSegmentMember | 4564000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02271-000PrecisionEquipmentBusinessReportableSegmentMember | 6918000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02271-000HealthcareBusinessReportableSegmentMember | 4556000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02271-000ComponentsBusinessReportableSegmentMember | 6641000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02271-000IndustrialMetrologyAndOthersReportableSegmentMember | 5620000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 378336521 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 378336521 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 378336521 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 378336521 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | 0 | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 69 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 58 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 398 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 484 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 78 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 40213 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 41300 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | 0 | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 1784950 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |